Datavault AI Inc. (NASDAQ: DVLT) has taken a significant step into the healthcare sector by forming DelivMeds AI, a joint venture with Wellgistics Health (NASDAQ: WGRX) that combines artificial intelligence, blockchain technology, and biometric verification to create a comprehensive healthcare delivery platform. The partnership, announced through a binding term sheet, involves three concurrent transactions with an expected aggregate asset value of $4 billion, subject to an independent fairness opinion.
The transactions include an expanded PharmacyChain(TM) license, the acquisition of QOLPOM intellectual property, and a controlling stake in Tollo Health. These moves are designed to support a national rollout of data-driven healthcare solutions that aim to improve patient engagement and streamline pharmacy operations. The platform will leverage Datavault AI's expertise in AI and data science, along with Wellgistics' healthcare infrastructure, to create a new model for direct-to-consumer healthcare delivery.
"This venture represents a transformative opportunity to apply our AI and blockchain capabilities to the healthcare industry, which is ripe for innovation," said a spokesperson for Datavault AI. "By combining our technologies with Wellgistics' market presence, we can offer solutions that enhance security, efficiency, and patient outcomes."
The DelivMeds AI platform will utilize AI-driven pharmacy optimization to manage inventory, predict demand, and reduce waste. Blockchain-enabled smart contracts will ensure secure and transparent transactions, while biometric verification will enhance patient identification and data security. The direct-to-consumer delivery component aims to make healthcare more accessible, particularly for patients with chronic conditions who require regular medications.
Datavault AI, known for its work in AI-driven data experiences and monetization in Web 3.0, has applications across multiple industries. Its Acoustic Sciences division holds patents in spatial audio technologies, while its Data Science division focuses on experiential data perception, valuation, and monetization. The company's Information Data Exchange(R) enables secure digital twins and licensing of name, image, and likeness through immutable metadata.
Wellgistics Health, a pharmaceutical logistics and healthcare technology company, brings expertise in pharmacy management and distribution. The partnership is expected to leverage both companies' strengths to create a scalable platform that can be deployed nationwide.
The $4 billion valuation reflects the potential of the combined assets and technologies, though it is subject to an independent fairness opinion. The transactions are expected to close pending regulatory approvals and other customary conditions. For more details, the full press release is available at https://ibn.fm/yIVh9.
Datavault AI is headquartered in Philadelphia, PA. Additional information about the company can be found at www.dvlt.ai. For the latest news and updates on Datavault AI, visit their newsroom at https://ibn.fm/DVLT.